John Joseph Hurley - 28 Apr 2022 Form 3 Insider Report for AVANOS MEDICAL, INC. (AVNS)

Role: Principal Accounting Officer
Signature: /s/ Mojirade James, attorney-in-fact for John Joseph Hurley
Issuer symbol: AVNS
Transactions as of: 28 Apr 2022
Net transactions value: $0
Form type: 3
Filing time: 04 May 2022, 07:18:56 UTC
Next filing: 11 May 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	AVNS	Common Stock						4,539	28 Apr 2022	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Reflects: (i) 346 shares of common stock held by the Reporting Person and (ii) 4,193 time-based restricted share units (RSUs) awarded to the Reporitng Person pursuant to the Issuer's Long-Term Incentive Plans, which RSUs vest as follows: (a) 115 will vest on May 8, 2022; (b) 319 will vest on June 9, 2022; (c) 1,585 will vest on October 29, 2022; (d) 89 will vest on March 4, 2023; (e) 1,586 will vest on October 29, 2023; (f) 318 will vest on December 9, 2023; (g) 89 will vest on March 4, 2024; and (h) 92 will vest on March 4, 2025.

Content

Reflects: (i) 346 shares of common stock held by the Reporting Person and (ii) 4,193 time-based restricted share units (RSUs) awarded to the Reporitng Person pursuant to the Issuer's Long-Term Incentive Plans, which RSUs vest as follows: (a) 115 will vest on May 8, 2022; (b) 319 will vest on June 9, 2022; (c) 1,585 will vest on October 29, 2022; (d) 89 will vest on March 4, 2023; (e) 1,586 will vest on October 29, 2023; (f) 318 will vest on December 9, 2023; (g) 89 will vest on March 4, 2024; and (h) 92 will vest on March 4, 2025.